Covidien opens China Technology Center, R&D unit in Shanghai
Leading global provider of healthcare products Covidien announced the opening of its China Technology Center and Research and Development facility in Shanghai.
"The establishment of this R&D facility in Shanghai strengthens Covidien’s continued commitment to provide innovative new products. It will also help healthcare providers worldwide improve patient care and extend healthcare delivery to more people and more places," said JosÃ© E. Almeida, Chairman, President and CEO of Covidien.
China is a key market in our global strategy, and this investment is a reflection of our strategic initiative. With a total investment of $45 million over a three year period, the China Technology Center will employ more than 300 people.
The facility spans more than 100,000 square feet, houses 17 laboratories and has state-of-the-art surgical and simulation suites that enables healthcare professionals to be actively involved in medical device design and development process.
Shanghai unit will provide a focal point to develop local Chinese talent and groom the next generation of medical innovators for the industry.
Dong Wu, Vice President, China RA&D Covidien said, “By collaborating closely with local medical experts who use our products, we can tailor devices to meet the demands of other emerging markets and China.” Mr. Covidien also said, “We recognize the immense potential of basing an R&D facility in Shanghai. This location will help us tap into internationally renowned experts based here in China, including the world-class engineering talent. We believe this collaboration will drive innovation in China and across the emerging markets healthcare landscape.”
Covidien is a global healthcare products company that creates innovative medical solutions for better patient outcomes and delivers value through the clinical leadership and excellence. The company has 43,000 employees worldwide in over 65 countries and its products are sold in more than 140 countries.
Vuram launches automated app to track COVID-19 supplies
A new app that tracks COVID-19 supplies in real time time has launched.
Built by hyper-automation services company Vuram, Trackable can monitor the progress of vaccines, oxygen cylinders, PPE, and masks as they move through the supply chain.
The app's features include street view to facilitate coordination between drivers, and trained facial recognition software powered by Microsoft Azure to ensure goods are only handled by authorised personnel.
Other functions include:
* Demand management for inventories, to prioritise deliveries using automation
* Demand analysis to predict sales trends based on stock levels
* Offline multilingual feature for drivers
* A dashboard to see the status and location of drivers
* Insights on how products are performing in real-time
The team at Vuram built Trackable as part of the Appian World 2021 Online Hackathon, where participants can take their ideas for innovative software and create a custom app. The tracking app went on to win the contest.
“Custom component building is at the heart of this application, and we focussed on making them more creative to provide an improved user experience" said Santosh Kumar, co-developer of Trackable.
"We are happy that we have managed to make it to the top in just a month. On behalf of Vuram, I thank the Appian Hackathon team for their efforts in conducting the event, and my hearty congratulations to all the winners."